Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
[Hybrid coronary revascularization for the treatment of coronary artery disease]
112th Ward, Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease,Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University,Beijing 100029, China.
Insights
Hybrid coronary revascularization (HCR) offers a combined approach to treating multivessel coronary artery disease, merging coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). This hybrid strategy shows promise for improved clinical outcomes compared to traditional CABG.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Medical Technology
Background:
- Multivessel coronary artery disease requires effective revascularization strategies.
- Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have limitations when used alone.
- Hybrid coronary revascularization (HCR) aims to leverage the benefits of both CABG and PCI.
Purpose of the Study:
- To evaluate the feasibility, safety, and potential superiority of HCR.
- To assess HCR as an alternative to conventional CABG for specific patient groups.
Main Methods:
- HCR involves minimally invasive direct coronary artery bypass (MIDCAB) of the left internal thoracic artery (LITA) to the left anterior descending artery (LAD).
- Non-LAD lesions are treated with PCI (stenting).
- Procedures can be performed in one-stop or staged hybrid settings.
Main Results:
- Available data suggest HCR is feasible and safe when performed by experienced teams.
- HCR may demonstrate superiority over conventional CABG in terms of clinical complications.
- Further large-scale randomized controlled trials are needed to confirm these findings.
Conclusions:
- HCR is a viable and potentially advantageous interventional strategy for selected patients with multivessel coronary artery disease.
- The combination of surgical and interventional techniques offers a promising approach.
- Wider adoption of HCR may be warranted following further validation.
Abstract:
Hybrid coronary revascularization (HCR) combines the respective strengths of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for selected patients with multivessel coronary artery disease. HCR includes the minimally invasive direct coronary artery bypass of a left internal thoracic artery graft to the left anterior descending artery (LAD) with stenting of non-LAD lesions with PCI, in onestop or staged hybrid procedures.HCR can prove superiority to conventional CABG in clinical complications. Many available data suggests that HCR is feasible and safe in skilled hands. Further large-scale randomized controlled trials are in great need. HCR may become another more commonly used interventional strategy for certain patients with multivessel coronary artery disease.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies

